SARS-CoV-2 and COVID-19
A section of Viruses (ISSN 1999-4915).
Section Information
-SARS-CoV-2
-immunity
-diseases
-epidemiology and evolution
-pneumonia
-bat virus
-vaccine design
-antiviral drug design
-treatment
-diagnosis
-prevention, prognosis and therapeutics
-clinical, medical and medicina
-public health research
-reverse genetics
-innate immunity
-adaptive immunity
-virus-host interactions
-animal models
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Basic Sciences for the Conquest of COVID-19 (Deadline: 31 May 2023)
- Influenza Virus and SARS-CoV-2 Structures: Entry, Replication, and Assembly (Deadline: 31 May 2023)
- The Secret Life of ACE2 as a Receptor for the Coronaviruses (Deadline: 31 May 2023)
- Molecular Epidemiology of SARS-CoV-2 (Deadline: 31 May 2023)
- Wastewater-Based Epidemiology (WBE) in COVID-19 Pandemics (Deadline: 30 June 2023)
- COVID-19 and Thrombosis 2023 (Deadline: 30 June 2023)
- Multiple Hosts of SARS-CoV-2 (Deadline: 30 June 2023)
- Coronavirus Genome Evolution, Recombination and Phylogeny (Deadline: 31 July 2023)
- SARS-CoV-2 and mRNA Vaccines (Deadline: 31 July 2023)
- COVID-19 Diagnostics in Clinical Applications and Pandemic Controls 2023 (Deadline: 31 July 2023)
- Evaluation of COVID-19 Booster Vaccine Effects (Deadline: 1 August 2023)
- SARS-CoV-2 in Pregnancy and Reproduction (Deadline: 15 August 2023)
- SARS-CoV-2 and Other Vaccines: Immunogenicity Parameters and Protection 2nd Edition (Deadline: 31 August 2023)
- Animal and Human Respiratory Viruses - Causes of the Next Pandemic? (Deadline: 31 August 2023)
- COVID-19 and Gastrointestinal Symptoms (Deadline: 30 September 2023)
- SARS-CoV-2 Neutralizing Antibodies 2.0 (Deadline: 30 September 2023)
- Emerging Concepts in SARS-CoV-2 Biology and Pathology (Deadline: 30 September 2023)
- Impact of Co-Infections in COVID-19: Predisposing Mechanisms and Interplay between Invasive Viral, Bacterial and Fungal Pathogens (Deadline: 1 November 2023)
- Immunogenicity and Safety of COVID-19 Vaccines: A Milestone Achieved in the Battle against the Pandemic (Deadline: 30 November 2023)
- COVID-19 and Pneumonia 2.0 (Deadline: 31 December 2023)
Topical Collection
Following topical collection within this section is currently open for submissions: